Senior Director, DTP Marketing, HIV Treatment jobs in United States
info-icon
This job has closed.
company-logo

Gilead Sciences · 3 days ago

Senior Director, DTP Marketing, HIV Treatment

Gilead Sciences is a leader in developing therapies for diseases such as HIV and hepatitis. They are seeking a Senior Director for Direct-to-Patient Marketing to lead innovative marketing strategies for a new HIV therapy, overseeing a dedicated team and driving impactful campaigns.

BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Leading DTP strategy, launch planning, and the annual patient marketing tactical plan
Developing targeted patient marketing approaches across personal and non-personal channels such as print, digital, social media, out-of-home advertising, and television
Generating and utilizing market research insights to enhance and refine promotional strategies and tactics
Creating culturally competent patient materials and collaborating with community partners and cross-functional teams to amplify the patient voice
Managing the DTP marketing team with responsibilities including hiring, coaching, performance management, and budget oversight
Closely managing integrated promotions and media budget and effectively optimizing execution
Overseeing agency relationships to leverage expertise and ensure campaign effectiveness
Ensuring compliance with all relevant laws, regulations, and policies

Qualification

Direct-to-Patient marketingPharmaceutical brand implementationPatient activationMarket research insightsBudget managementChange managementLeadership skillsInterpersonal skillsCommunication skillsTeam management

Required

Bachelor's degree with at least 14 years of marketing experience, or
Master's degree or PhD with at least 12 years of marketing experience
Demonstrated high performance in Direct-to-Patient (DTP) marketing, with the ability to set vision and lead diverse stakeholders
Strategic and analytical thinking to make accountable decisions and prioritize tradeoffs
Deep expertise in pharmaceutical brand implementation, communication planning, and patient activation
Proven track record in pharma/biotech and consumer patient/community marketing
Strong leadership skills encompassing change management, recruitment, and performance management
Excellent interpersonal and communication skills for cross-functional collaboration and influence
Strong executive presence, commanding respect through sound business judgment and clear decision-making
Superior budget management skills, including OPEX forecasting and tracking
Experience developing external relationships that foster brand advocacy
Prior direct people management experience with proven abilities to lead complex marketing initiatives and inspire teams toward impactful outcomes

Preferred

An MBA with 12+ years of pharma/biotech marketing experience
Experience in product launch and portfolio management
Background working with patient and community advocacy groups
Knowledge of pharmaceutical regulatory requirements impacting marketing materials
Prior experience with advertising, digital, or communications agencies is advantageous

Benefits

Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans

Company

Gilead Sciences

company-logo
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

H1B Sponsorship

Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)

Funding

Current Stage
Public Company
Total Funding
$4.41B
Key Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B

Leadership Team

leader-logo
Keeley Wettan
Senior Vice President, Legal
linkedin
leader-logo
Patrick Loerch
Senior Vice President, Clinical Data Science
linkedin
Company data provided by crunchbase